These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 17898126)

  • 21. Glucagon-like peptide-1 as a key regulator of lipid and lipoprotein metabolism in fasting and postprandial states.
    Farr S; Taher J; Adeli K
    Cardiovasc Hematol Disord Drug Targets; 2014; 14(2):126-36. PubMed ID: 24801723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GLP-1 tablet in type 2 diabetes in fasting and postprandial conditions.
    Gutniak MK; Larsson H; Sanders SW; Juneskans O; Holst JJ; Ahrén B
    Diabetes Care; 1997 Dec; 20(12):1874-9. PubMed ID: 9405910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GLP-1 attenuates intestinal fat absorption and chylomicron production via vagal afferent nerves originating in the portal vein.
    Hoffman S; Alvares D; Adeli K
    Mol Metab; 2022 Nov; 65():101590. PubMed ID: 36067913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GLP-1 reduces intestinal lymph flow, triglyceride absorption, and apolipoprotein production in rats.
    Qin X; Shen H; Liu M; Yang Q; Zheng S; Sabo M; D'Alessio DA; Tso P
    Am J Physiol Gastrointest Liver Physiol; 2005 May; 288(5):G943-9. PubMed ID: 15677555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gut incretin hormones in identical twins discordant for non-insulin-dependent diabetes mellitus (NIDDM)--evidence for decreased glucagon-like peptide 1 secretion during oral glucose ingestion in NIDDM twins.
    Vaag AA; Holst JJ; Vølund A; Beck-Nielsen HB
    Eur J Endocrinol; 1996 Oct; 135(4):425-32. PubMed ID: 8921824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is GLP-1 a hormone: Whether and When?
    D'Alessio D
    J Diabetes Investig; 2016 Apr; 7 Suppl 1(Suppl 1):50-5. PubMed ID: 27186356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraportal GLP-1 stimulates insulin secretion predominantly through the hepatoportal-pancreatic vagal reflex pathways.
    Nishizawa M; Nakabayashi H; Uehara K; Nakagawa A; Uchida K; Koya D
    Am J Physiol Endocrinol Metab; 2013 Aug; 305(3):E376-87. PubMed ID: 23715725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of apolipoprotein A-IV in regulating glucagon-like peptide-1 secretion.
    Wang F; Yang Q; Huesman S; Xu M; Li X; Lou D; Woods SC; Marziano C; Tso P
    Am J Physiol Gastrointest Liver Physiol; 2015 Oct; 309(8):G680-7. PubMed ID: 26294669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucagon-like peptide 1 abolishes the postprandial rise in triglyceride concentrations and lowers levels of non-esterified fatty acids in humans.
    Meier JJ; Gethmann A; Götze O; Gallwitz B; Holst JJ; Schmidt WE; Nauck MA
    Diabetologia; 2006 Mar; 49(3):452-8. PubMed ID: 16447057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The intestinal hormone glucagon-like peptide 1 (GLP-1): from experiment to the clinic].
    Göke B; Fehmann HC; Schirra J; Hareter A; Göke R
    Z Gastroenterol; 1997 Apr; 35(4):285-94. PubMed ID: 9221612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastrointestinal actions of glucagon-like peptide-1-based therapies: glycaemic control beyond the pancreas.
    Smits MM; Tonneijck L; Muskiet MH; Kramer MH; Cahen DL; van Raalte DH
    Diabetes Obes Metab; 2016 Mar; 18(3):224-35. PubMed ID: 26500045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects.
    Vilsbøll T; Krarup T; Madsbad S; Holst JJ
    Regul Pept; 2003 Jul; 114(2-3):115-21. PubMed ID: 12832099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bedtime administration of NN2211, a long-acting GLP-1 derivative, substantially reduces fasting and postprandial glycemia in type 2 diabetes.
    Juhl CB; Hollingdal M; Sturis J; Jakobsen G; Agersø H; Veldhuis J; Pørksen N; Schmitz O
    Diabetes; 2002 Feb; 51(2):424-9. PubMed ID: 11812750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elimination of the action of glucagon-like peptide 1 causes an impairment of glucose tolerance after nutrient ingestion by healthy baboons.
    D'Alessio DA; Vogel R; Prigeon R; Laschansky E; Koerker D; Eng J; Ensinck JW
    J Clin Invest; 1996 Jan; 97(1):133-8. PubMed ID: 8550824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The incretins: a link between nutrients and well-being.
    Burcelin R
    Br J Nutr; 2005 Apr; 93 Suppl 1():S147-56. PubMed ID: 15877888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of intestinal proglucagon-derived peptide secretion by glucose-dependent insulinotropic peptide in a novel enteroendocrine loop.
    Roberge JN; Brubaker PL
    Endocrinology; 1993 Jul; 133(1):233-40. PubMed ID: 8319572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nateglinide stimulates glucagon-like peptide-1 release by human intestinal L cells via a K(ATP) channel-independent mechanism.
    Kitahara Y; Miura K; Yasuda R; Kawanabe H; Ogawa S; Eto Y
    Biol Pharm Bull; 2011; 34(5):671-6. PubMed ID: 21532155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exogenously imposed postprandial-like rises in systemic glucose and GLP-1 do not produce an incretin effect, suggesting an indirect mechanism of GLP-1 action.
    Ionut V; Liberty IF; Hucking K; Lottati M; Stefanovski D; Zheng D; Bergman RN
    Am J Physiol Endocrinol Metab; 2006 Oct; 291(4):E779-85. PubMed ID: 16720628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients.
    Herrmann C; Göke R; Richter G; Fehmann HC; Arnold R; Göke B
    Digestion; 1995; 56(2):117-26. PubMed ID: 7750665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucagon-like peptide 2 stimulates glucagon secretion, enhances lipid absorption, and inhibits gastric acid secretion in humans.
    Meier JJ; Nauck MA; Pott A; Heinze K; Goetze O; Bulut K; Schmidt WE; Gallwitz B; Holst JJ
    Gastroenterology; 2006 Jan; 130(1):44-54. PubMed ID: 16401467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.